Astrazeneca (NYSE:AZN) Receives Buy Rating from Jefferies Financial Group
Astrazeneca (NYSE:AZN – Get Free Report)‘s stock had its “buy†rating reiterated by analysts at Jefferies Financial Group in a report issued on Wednesday,MarketScreener reports. AZN has been the subject of a number of other research reports. TD Cowen restated a “buy†rating on shares of Astrazeneca in a research note on Wednesday, March 18th. […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.